Aardvark Therapeutics Inc
Research Aardvark Therapeutics Inc (AARD) on Bullrun: market cap USD 113.01M. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerAARD
- ExchangeNASDAQ
- CountryUnited States
- SectorHealthcare
- IndustryBiotechnology
- CurrencyUSD
- Market capUSD 113.01M
- Financial periodFY2025
- Net income-USD 57.59M
- Free cash flow-USD 54.27M
Valuation Snapshot
latest market cap is USD 113.01M.
About Aardvark Therapeutics Inc
Aardvark Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing small-molecule therapeutics to activate innate homeostatic pathways for the treatment of metabolic diseases. Aardvark Therapeutics, Inc. was incorporated in 2017 and is headquartered in San Diego, California.
Frequently asked questions
What is Aardvark Therapeutics Inc's market cap?
Aardvark Therapeutics Inc's market capitalization is USD 113.01M.
What does Aardvark Therapeutics Inc do?
Aardvark Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing small-molecule therapeutics to activate innate homeostatic pathways for the treatment of metabolic diseases. Aardvark Therapeutics, Inc.